Apr 08, 2025 8:30am EDT FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics
Apr 02, 2025 8:30am EDT FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
Mar 31, 2025 4:25pm EDT FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
Mar 21, 2025 8:30am EDT FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting
Mar 04, 2025 8:30am EST FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
Feb 27, 2025 8:30am EST FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic
Feb 05, 2025 9:15am EST FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates